(Q24304277)

placental growth factor-activated receptor activity

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Christoph Dehio

20

0 references

Kurt Ballmer-Hofer

13

0 references

Diether Lambrechts

6

0 references

Mieke Dewerchin

16

Mieke Dewerchin

0 references

Stephane Plaisance

Stephane Plaisance

8

0 references

Edward M. Conway

Edward M Conway

27

0 references

Johannes Waltenberger

Johannes Waltenberger

2

0 references

Peter Carmeliet

28

Peter Carmeliet

0 references

Daniel J. Hicklin

21

Daniel J Hicklin

0 references

Lieve Moons

Lieve Moons

5

1 reference

ORCID Public Data File 2021

Désiré Collen

26

Désiré Collen

0 references

Monica Autiero

1

Monica Autiero

0 references

Françoise Bono

10

Françoise Bono

0 references

Jean-Marc Herbert

23

Jean-Marc Herbert

0 references

Masabumi Shibuya

25

Masabumi Shibuya

0 references

author name string

Didier Communi

3

0 references

Andrea Kranz

4

0 references

Jens Kroll

7

0 references

Maria De Mol

9

0 references

Stefanie Kliche

11

0 references

Guido Fellbrich

12

0 references

Domenico Maglione

14

0 references

Ulrike Mayr-Beyrle

15

0 references

Saskia Dombrowski

17

0 references

Danica Stanimirovic

18

0 references

Paul Van Hummelen

19

0 references

Graziella Persico

22

0 references

David Communi

Age-dependent impairment of angiogenesis

24

0 references

language of work or name

English

0 references

publication date

July 2003

0 references

published in

Nature Medicine

0 references

volume

9

0 references

issue

7

0 references

page(s)

936-43

0 references

cites work

1 reference

7 January 2021

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice

1 reference

7 January 2021

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications

1 reference

7 January 2021

Structure and function of placental growth factor

1 reference

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

7 January 2021

Role of vascular endothelial growth factor in regulation of physiological angiogenesis

1 reference

7 January 2021

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

7 January 2021

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

7 January 2021

Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways

1 reference

7 January 2021

Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1.

1 reference

7 January 2021

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

1 reference

7 January 2021

Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors

1 reference

7 January 2021

Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells

1 reference

7 January 2021

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

1 reference

7 January 2021

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

1 reference

7 January 2021

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment

1 reference

7 January 2021

Effects of angiogenic growth factor combinations on retinal endothelial cells

1 reference

7 January 2021

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

1 reference

7 January 2021

Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers

1 reference

7 January 2021

In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor

1 reference

7 January 2021

Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer

1 reference

7 January 2021

Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers

1 reference

7 January 2021

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

1 reference

7 January 2021

Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization

1 reference

7 January 2021

Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding

1 reference

7 January 2021

Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.

1 reference

7 January 2021

Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules

1 reference

7 January 2021

Signal transduction by VEGF receptor-1 wild type and mutant proteins

1 reference

7 January 2021

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

7 January 2021

Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells

1 reference

7 January 2021

Integration of signals from receptor tyrosine kinases and g protein-coupled receptors.

1 reference

7 January 2021

Interplay between integrins and FLK-1 in shear stress-induced signaling

1 reference

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

7 January 2021

Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability

1 reference

7 January 2021

Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites

1 reference

7 January 2021

SH2 domains recognize specific phosphopeptide sequences

1 reference

7 January 2021

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor

1 reference

7 January 2021

The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution

1 reference

7 January 2021

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

1 reference

7 January 2021

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

7 January 2021

RNA amplification results in reproducible microarray data with slight ratio bias

1 reference

7 January 2021